Brown E M, Dawson-Hughes B F, Wilson R E, Adragna N
J Clin Endocrinol Metab. 1981 Nov;53(5):1064-71. doi: 10.1210/jcem-53-5-1064.
We investigated the presence and several of the properties of calmodulin in human parathyroid cells. Boiled extracts of such cell preparations contained a heat-stable factor causing a 2- to 3-fold calcium-dependent stimulation of calmodulin-deficient phosphodiesterase activity, which was parallel to that due to pure porcine calmodulin. This activation could be totally blocked by 10(-4) M trifluoperazine, with half-maximal inhibition at 3 X 10(-5) M, similar to the effects of this phenothiazine on porcine calmodulin. These results suggested the presence of calmodulin in human parathyroid cells. By comparison with known quantities of porcine calmodulin, human parathyroid cells contained 9-208 ng calmodulin/10(6) cells. The content of calmodulin in 3 normal parathyroid glands [65 +/- 8 (+/- SEM) ng/10(6) cells] did not differ significantly from that of 12 adenomas (61 +/- 16 ng/10(6) cells). Cells from 7 glands showing secondary hyperplasia, however, had significantly greater levels of calmodulin (164 +/- 11 ng/10(6) cells) than either normal cells or adenomas (P less than 0.001 and P less than 0.005, respectively). Extracts of human parathyroid cells caused half-maximal stimulation of phosphodiesterase activity at 1.1-4.8 microM free calcium. The concentrations of calcium half-maximally activating phosphodiesterase (Ka) did not differ significantly for normal or abnormal cells (3.3 +/- 0.03 vs. 2.6 +/- 0.33; P greater than 0.3). Moreover, in 2 cases in which normal parathyroid tissue was obtained from patients with adenomas, the Ka values for calcium for the normal and abnormal cells were similar (3.3 vs. 2.5 and 3.4 vs. 2.5 microM, respectively). Finally, there was no significant correlation between either the content of calmodulin or the Ka for calcium and the set-point for calcium [the calcium concentration causing half-maximal inhibition of parathyroid hormone (PTH) release] or the maximal rate of PTH secretion for dispersed parathyroid cells. These results suggest that human parathyroid cells contain calmodulin, but provide no evidence for a role of this protein in the abnormal calcium-regulated PTH release in hyperparathyroidism.
我们研究了人类甲状旁腺细胞中钙调蛋白的存在及其若干特性。此类细胞制剂的煮沸提取物含有一种热稳定因子,可使缺乏钙调蛋白的磷酸二酯酶活性产生2至3倍的钙依赖性刺激,这与纯猪钙调蛋白所引起的刺激相似。这种激活作用可被10⁻⁴ M三氟拉嗪完全阻断,在3×10⁻⁵ M时产生半数最大抑制,类似于这种吩噻嗪对猪钙调蛋白的作用。这些结果表明人类甲状旁腺细胞中存在钙调蛋白。与已知量的猪钙调蛋白相比,人类甲状旁腺细胞每10⁶个细胞含有9 - 208 ng钙调蛋白。3个正常甲状旁腺组织(65±8(±标准误)ng/10⁶个细胞)中的钙调蛋白含量与12个腺瘤组织(61±16 ng/10⁶个细胞)相比,无显著差异。然而,来自7个呈现继发性增生的腺体的细胞,其钙调蛋白水平(164±11 ng/10⁶个细胞)显著高于正常细胞或腺瘤组织(分别为P<0.001和P<0.005)。人类甲状旁腺细胞提取物在游离钙浓度为1.1 - 4.8 μM时引起磷酸二酯酶活性的半数最大刺激。正常或异常细胞使磷酸二酯酶半数最大激活的钙浓度(Ka)无显著差异(3.3±0.03对2.6±0.33;P>0.3)。此外,在2例从患有腺瘤的患者获取正常甲状旁腺组织的病例中,正常细胞和异常细胞的钙Ka值相似(分别为3.3对2.5以及3.4对2.5 μM)。最后,钙调蛋白含量或钙Ka值与钙调定点[引起甲状旁腺激素(PTH)释放半数最大抑制的钙浓度]或分散的甲状旁腺细胞的PTH最大分泌速率之间均无显著相关性。这些结果表明人类甲状旁腺细胞含有钙调蛋白,但没有证据表明该蛋白在甲状旁腺功能亢进时异常的钙调节PTH释放中起作用。